Oxidative stress and cardiac disease

American Journal of Medicine

Volumn 109, Issue 4, 2000, Pages 315-323

  Lefer, David J ^a   Granger, D Neil ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REACTIVE OXYGEN METABOLITE;

CELL DEATH; CELL INFILTRATION; HEART DISEASE; HUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ANIMAL; ANTIOXIDANTS; CARDIOVASCULAR PHYSIOLOGY; CORONARY DISEASE; FEMALE; HUMAN; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL STUNNING; MYOCARDIUM; OXIDATIVE STRESS; PROGNOSIS; REACTIVE OXYGEN SPECIES; RISK ASSESSMENT;

EID: 0033833788     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(00)00467-8     Document Type: Review

References (80)

1. Phase I, National Health and Nutrition Examination Survey III (1988-91).
2. National Hospital Ambulatory Medical Care Survey - 1996 (CDC/NCHS).
3. Kannel W.B., Castelli W.P., Gordon T. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med. 90:1979;85-91.
4. Keys A. Coronary heart disease in seven countries. Circulation. 41:(suppl I):1970;1-8.
5. Koren G., Weiss A.T., Hasin Y., et al. Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. N Engl J Med. 313:1985;1384-1389.
6. Braunwald E., Kloner R.A. Myocardial reperfusion a double-edged sword? J Clin Invest. 76:1985;1713-1719.
7. Simpson P.J., Lucchesi B.R. Free radicals and myocardial ischemia and reperfusion injury. J Lab Clin Med. 110:1987;13-27.
8. Hansen P.R. Role of neutrophils in myocardial ischemia and reperfusion. Circulation. 91:1995;1872-1885.
9. Tsao P.S., Aoki N., Lefer D.J., Johnson G., Lefer A.M. Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation. 82:1990;1402-1412.
10. Ma X.-L., Weyrich A.S., Lefer D.J., Lefer A.M. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res. 72:1993;403-412.
11. Lucchesi B.R. Modulation of leukocyte-mediated myocardial reperfusion injury. Annu Rev Physiol. 52:1990;561-576.
12. Ku D.D. Coronary vascular reactivity after acute myocardial ischemia. Science. 218:1982;576-578.
13. Van Benthuysen K.M., McMurtry I.F., Horwitz L.D. Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro. J Clin Invest. 79:1987;265-274.
14. Lefer D.J., Nakanishi K., Vinten-Johansen J., Ma X.-L., Lefer A.M. Cardiac venous endothelial dysfunction after myocardial ischemia and reperfusion in dogs. Am J Physiol. 263:1992;H850-H1246.
15. McCord J.M. Free radicals and myocardial ischemia overview and outlook . Free Rad Biol Med. 4:1988;9-14.
16. Werns S.W., Lucchesi B.R. Myocardial ischemia and reperfusion the role of oxygen radicals in tissue injury . Card Drugs Therap. 2:1989;761-769.
17. Kramer J.H., Arroyo C.M., Dickens B.F., Welicki W.B. Spin trapping evidence that graded myocardial ischemia alters post-ischemic superoxide production. Free Rad Biol Med. 3:1987;153-159.
18. Zweier J.L., Flaherty J.T., Weisfeldt M.L. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci USA. 84:1987;1404-1407.
19. Zweier J.L., Kuppusamy P., Williams R., et al. Measurement and characterization of postischemic free radical generation in the isolated perfused heart. J Biol Chem. 264:1989;18890-18895.
20. Garlick P.B., Davies M.J., Hearse D.J., Slater T.F. Direct detection of free radicals in reperfused heart using electron spin resonance spectroscopy. Circ Res. 61:1987;757-760.
21. Zweier J.L., Kuppasamy P.A., Lutty G.A. Measurement of endothelial cell free radical generation evidence for a central mechanism of free radical injury in postischemic tissue . Proc Natl Acad Sci USA. 85:1988;4046-4050.
22. Bolli R. Mechanisms of myocardial stunning. Circulation. 82:1990;723-738.
23. Flitter W.D. Free radicals and myocardial reperfusion injury. Br Med Bull. 49:1993;545-555.
24. Weiss J.N., Goldhaber J.I., Sen J. Oxygen free radicals in the pathophysiology of myocardial ischemia/reperfusion. Tarr M., Samson F. Oxygen Free Radicals in Tissue Damage. 1993;250-266 Brinkhauser, Boston.
25. Tarr M, Valenzeno DP. Reactive oxygen-induced modification of cardiac electrophysiology: a comparison of the effects of Rose Bengal and other reactive oxygen generators. In: Tarr M, Samson F, eds. Oxygen Free Radicals in Tissue Damage. Boston: Brinkhauser, 1993:267-284.
26. Jolly S.R., Kane W.J., Baile M.B., Abrams G.D., Lucchesi B.R. Canine myocardial reperfusion injury its reduction by the combined administration of superoxide dismutase and catalase . Circ Res. 54:1984;277-285.
27. Ambrosio G., Becker L.C., Hutchins G.M., Weisman H.F., Weisfeldt M.L. Reduction in experimental infarct size by recombinant human superoxide dismutase insights into the pathophysiology of reperfusion injury . Circulation. 74:1986;1424-1433.
28. Chambers DE, Parks DA, Patterson G, et al. Xanthine oxidase as a source of free radical damage in myocardial ischemia. J Mol Cell Cardiol 1985;17:145-152.
29. Werns S.W., Simpson P.J., Mickelson J.K., Shea M.J., Pitt B., Lucchessi B.R. Sustained limitation by superoxide dismutase of canine myocardial injury due to regional ischemia followed by reperfusion. J Cardiovasc Pharmacol. 11:1998;36-44.
30. Werns S.W., Shea M.J., Driscoll E.M., et al. The independent effects of oxygen radical scavengers on canine infarct size. Circ Res. 56:1985;895-898.
31. Naslund U., Haggmark S., Johansson G., Marklund S.L., Reiz S., Oberg A. Superoxide dismutase and catalase reduce infarct size in a porcine myocardial occlusion reperfusion model. J Mol Cell Cardiol. 18:1986;1077-1084.
32. Ma X.L., Johnson G. II, Lefer A.M. Low doses of superoxide dismutase and a stable prostacyclin analogue protect in myocardial ischemia and reperfusion. J Am Coll Cardiol. 19:1992;197-204.
33. Mehta J.L., Nichols W.W., Donnelly W.H., et al. Protection by superoxide dismutase from myocardial dysfunction and attenuation of vasodilator reserve after coronary occlusion and reperfusion in dog. Circ Res. 65:1989;1283-1295.
34. Gallagher K.P., Buda A.J., Pace D., Gerren R.A., Shafler M. Failure of superoxide dismutase and catalase to alter size of infarction in concious dogs after 3 hours of occlusion followed by reperfusion. Circulation. 73:1986;1065-1076.
35. Uraizee A., Reimer K.A., Murray C.E., Jennings R.B. Failure of superoxide dismutase to limit size of myocardial infarction after 40 minutes of ischemia and 4 days of reperfusion in dogs. Circulation. 75:1987;1237-1248.
36. Nejima J., Knight D.R., Fallon J.T., et al. Superoxide dismutase reduces reperfusion arrhythmias but fails to salvage regional function or myocardium at risk in conscious dogs. Circulation. 79:1989;143-153.
37. Shirato C., Miura T., Downey J.M. Superoxide dismutase (single dose) delays rather than prevents necrosis in reperfused rabbit heart. FASEB J. 2:1988;A918.
38. Klein H.H., Pich S., Lindert S., Buchwald A., Kreuzer H. Intracoronary superoxide dismutase for the treatment of "reperfusion injury" a blind randomized placebo-controlled trial in ischemic-reperfused procine hearts . Bas Res Cardiol. 83:1998;141-148.
39. Patel B., Jeroudi M.O., O'Neill P.G., Roberts R., Bolli R. Human superoxide dismutase fails to limit infarct size after 2 hours ischemia and reperfusion. Circulation. 2:1988;A918.
40. Richard V.J., Murry C.E., Jennings R.B., Reimer K.A. Therapy to reduce free radicals during early reperfusion does not limit the size of myocardial infarcts caused by 90 minutes of ischemia in dogs. Circulation. 78:1988;473-480.
41. Engler R., Gilpin E. Can superoxide dismutase alter infarct size? Circulation. 79:1989;1137-1142.
42. Tamura Y., Chi L., Driscoll E., et al. Superoxide dismutase conjugated to polyethylene glycol provides sustained protection against myocardial ischemia/reperfusion injury in canine heart. Circ Res. 63:1988;944-959.
43. Ooiwa B.A., Jordan M.C., Downey J.M., McCord J.M. PEG-SOD fails to limit infarct size in reperfused rabbit heart. Circulation. 80:1989;II-294.
44. Hori M., Goto K., Iwa K., et al. Effects of long-acting superoxide dismutase (SMA-SOD) on myocardial necrosis in coronary embolization in dogs. Circulation. 78:1988;II-372.
45. Kilgore K.S., Friedrichs G.S., Johnson C.R., et al. Protective effects of the SOD-mimetic SC-52608 against ischemia/reperfusion damage in the rabbit isolated heart. J Mol Cell Cardiol. 26:1994;995-1006.
46. White C.W., Avraham K.B., Shanley P.F., Groner Y. Transgenic mice with expression of elevated levels of copper-zinc superoxide dismutase are resistant to pulomary oxygen toxicity. J Clin Invest. 87:1991;2162-2168.
47. Wispe J.R., Warner B.B., Clark J.C., et al. Human Mn-superoxide dismutase in pulmonary epithelial cells of transgenic mice confers protection from oxgyen toxicity. J Biol Chem. 267:1992;23937-23941.
48. Ho Y.-S., Vincent R., Dey M.S., Slot J.W., Crapo J.D. Transgenic models for the study of lung antioxidant defense enhanced manganese-containing superoxide dismutase activity gives partial protection to B6C3 hybrid mice exposed to hyperoxia . Am J Respir Cell Mol Biol. 18:1998;538-547.
49. Yen H-C, Oberley TD, Vichitbandha S, Ho Y-S, St. Clair DK. The protective role of mangansese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. J Clin Invest 1996;98:1253-1260.
50. Ho Y.-S., Magnenat J.-L., Bronson R.T., et al. Mice deficient in cellular glutathione peroxidase develop normally and show no increased sensitivity to hyperoxia. J Biol Chem. 272:1997;16644-16651.
51. Jaeschke H, Ho Y-S, Fisher MA, Lawson JA, AF. Glutathione peroxidase-deficient mice are more susceptible to neutrophil-mediated hepatic parenchymal cell injury during endotoxemia: importance of an intracellular oxidant stress. Hepatology 1999;29:443-450.
52. Beck M.A., Esworthy R.S., Ho Y.-S., Chu F.-F. Glutathione peroxidase protects mice from viral-induced myocarditis. FASEB J. 12:1998;1143-1149.
53. Yoshida T., Watanabe M., Engleman D.T., et al. Transgenic mice overexpressing glutathione peroxidase are resistant to myocardial ischemia reperfusion injury. J Mol Cell Cardiol. 28:1996;1759-1767.
54. Chen E.P., Bittner H.B., Davis R.D., Folz R.J., Van Trigt P. Extracellular superoxide dismutase transgene overexpression preserves postischemic myocardial function in isolated murine hearts. Circulation. 94:(suppl 9):1996;II412-II417.
55. Chen Z., Siu B., Ho Y.-S., et al. Overexpression of MnSOD protects against myocardial ischemia/reperfusion injury in transgenic mice. J Mol Cell Cardiol. 30:1998;2281-2289.
56. Yoshida T., Maulik N., Engleman R.M., et al. Glutathione peroxidase knockout mice are susceptible to myocardial ischemia reperfusion injury. Circulation. 96:1997;II-216-II-220.
57. Suguhara T., Horikawa M., Hikita M., Nagata H. Studies on a sulfhydryl radioprotector of low toxicity. Experientia. 27:1977;53-61.
58. Devi P. Chemical radiation protection by alpha-mercapto-propionyl glycine. J Nucl Med Allied Sci. 27:1983;327-336.
59. Mitsos S.E., Fantone J.C., Gallagher K.P., et al. Canine myocardial reperfusion injury protection by a free radical scavenger, N-2-mercaptopropionyl glycine . J Card Pharmacol. 8:1986;978-988.
60. Mitsos S.E., Askew T.E., Fantone J.C., et al. Protective effects of N-3-mercaptopropionyl glycine against myocardial reperfusion injury after neutrophil deopletion in the dog evidence for the role of intracellular-derived free radicals . Circulation. 73:1986;1077-1086.
61. Horwitz L.D., Fennessey P.V., Shikes R.H., Kong Y. Marked reduction in myocardial infarct size due to prolonged infusion of an antioxidant during reperfusion. Circulation. 89:1994;1792-1801.
62. Forman M.B., Puett D.W., Cates C.U., et al. Glutathione redox pathway and reperfusion injury effect of N-acetylcysteine on infarct size and ventricular function . Circulation. 78:1988;202-213.
63. Carrea F.P., Lesnefskey E.J., Repine J.E., Shikes R.H., Horwitz L.D. Reduction of canine myocardial infarct size by a diffusible reactive oxygen metabolite scavenger efficacy of dimethylthiourea given at the onset of reperfusion . Circ Res. 68:1991;1652-1659.
64. Williams R.E., Zweier J.L., Flaherty J.T. Treatment with deferoxamine during ischemia improves functional and metabolic recovery and reduces reperfusion-induced oxygen radical generation in rabbit hearts. Circulation. 83:1991;1006-1014.
65. Farber N.E., Vercellotti G.M., Jacob H.S., Pieper G.H., Gross G.J. Evidence for a role of iron-catalyzed oxidants in functional and metabolic stunning in the canine heart. Circ Res. 63:1988;351-360.
66. Bolli R., Jeroudi M.O., Patel B.S., et al. Direct evidence that oxygen derived free radicals contribute to postischemic myocardial dysfunction in the intact dog. Proc Natl Acad Sci USA. 86:1989;4695-4699.
67. Hess M.L., Kukreja C. Free radicals, calcium homeostasis, heat shock proteins, and myocardial stunning. Ann Thorac Surg. 60:1995;760-766.
68. Przyklenk K., Kloner R.A. Superoxide dismutase plus catalase improves contractile function in the canine model of the "stunned myocardium" Circ Res. 58:1986;148-156.
69. Jeroudi M.O., Triana F.J., Patel B.S., Bolli M. Effect of superoxide dismutase and catalase, given seperately, on myocardial "stunning" Am J Physiol. 259:1990;H889-H890.
70. Buchwald A., Klein H.H., Lindert, et al. Effect of intracoronary superoxide dismutase on regional function in stunned myocardium. J Card Pharmacol. 13:1989;258-264.
71. Gross G.J., Farger N.E., Hardman H.F., Warltier D.C. Beneficial actions of superoxide dismutase and catalase in stunned myocardium of dogs. Am J Physiol. 250:1986;H373-H377.
72. Bolli R., Patel B., Zhu W., et al. The iron chelator desferrioxamine attenuates postischemic ventricular dysfunction. Am J Physiol. 252:1987;H1372-H1380.
73. Murohara Y., Yoshiki Y., Hattori R., Kawai C. Effects of superoxide dismutase on reperfusion arrhythmias and left ventricular function in patients undergoing thrombolysis for anterior wall acute myocardial infarction. Am J Cardiol. 67:1991;765-767.
74. Flaherty J.T., Pitt B., Gruber J.W., et al. Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction. Circulation. 89:1994;1982-1991.
75. Maxwell I S.R.J., Lip G.Y.H. Reperfusion injury a review of the pathophysiology, clinical manifestations and therapeutic options . Int J Cardiol. 58:1997;95-117.
76. Downey J.M., Yellon D.M. Do free radicals contribute to myocardial cell death during ischemia-reperfusion? Yellon D.M., Jennings R.B. Myocardial Protection Pathophysiology of Reperfusion and Reperfusion Injury . 1992;35-57 Raven Press, New York.
77. Lefer A.M., Lefer D.J. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischemia-reperfusion. Card Res. 32:1996;743-751.
78. Palazzo A.J., Jones S.P., Anderson D.C., Granger D.N., Lefer D.J. Coronary endothelial P-selectin in the pathogenesis of myocardial ischemia-reperfusion injury. Am J Physiol. 275:1998;H1865-H1872.
79. Palazzo A.J., Jones S.P., Girod W.G., Anderson D.C., Granger D.N., Lefer D.J. Myocardial ischemia-reperfusion injury in CD18- and ICAM-1-deficient mice. Am J Physiol. 275:1998;H2300-H2307.
80. Granger D.N. Ischemia-reperfusion mechanisms of microvascular dysfunction and the influence of risk factors for cardiovascular disease . Microcirculation. 6:1999;167-178.